Abstract
Coronary artery bypass graft (CABG) surgery has been a mainstay in the treatment of coronary artery disease. Diabetes is prevalent in these patients and has significant effects in the operative period as well as in long-term survival. Diabetes is a risk factor in increased incidence of mortality as well as deep sternal wound infection after CABG surgery. Long-term survival is also significantly affected by diabetes. Clinicians who treat diabetic patients with coronary artery disease should be aware of the effects this condition has on the outcomes of CABG surgery.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
American Heart Association: Cardiovascular Procedures—Statistics, 2004. Available at http://www.americanheart.org/downloadable/heart/1136820889417CardiovascularProc06.pdf. Accessed November 6, 2006.
American Diabetes Association: Total Prevalence of Diabetes & Pre-diabetes. Available at http://www.diabetes.org/diabetes-statistics/prevalence.jsp. Accessed November 6, 2006.
Whang W, Bigger JT Jr: Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators. J Am Coll Cardiol 2000, 36:1166–1172.
Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) [no authors listed]. Circulation 1997, 96:1761–1769.
Sedlis SP, Morrison DA, Lorin JD, et al.: Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 2002, 40:1555–1566.
Leavitt BJ, Sheppard L, Maloney C, et al.: Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 2004, 110(11 suppl 1):II41–II44.
Lilienfeld DE, Vlahov D, Tenney JH, McLaughlin JS: Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control 1988, 16:3–6.
Braxton JH, Marrin CA, McGrath PD, et al.: Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg 2000, 70:2004–2007.
Loop FD, Lytle BW, Cosgrove DM, et al.: Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990, 49:179–186.
Grossi EA, Esposito R, Harris LJ, et al.: Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg 1991, 102:342–346; discussion 346–347.
Matsa M, Paz Y, Gurevitch J, et al.: Bilateral skeletonized internal thoracic artery grafts in patients with diabetes mellitus. J Thorac Cardiovasc Surg 2001, 121:668–674.
Edwards FH, Grover FL, Shroyer ALW, et al.: The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg 1997, 63:903–908.
Clough RA, Leavitt BJ, Morton JR, et al.: The effect of comorbid illness on mortality outcomes in cardiac surgery. Arch Surg 2002, 137:428–432; discussion 432–433.
Schwartz L, Kip KE, Frye RL, et al.: Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 2002, 106:2652–2658.
Detre KM, Lombardero MS, Brooks MM, et al.: The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med 2000 342:989–997.
Niles NW, McGrath PD, Malenka D, et al.: Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 2001, 37:1008–1015.
Weintraub WS, Stein B, Kosinski A, et al.: Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol 1998, 31:10–19.
Abizaid A, Costa MA, Centemero M, et al.: Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001, 104:533–538.
Flaherty JD, Davidson CJ: Diabetes and coronary revascularization. JAMA 2005, 293:1501–1508.
Zerr KJ, Furnary AP, Grunkemeier GL, et al.: Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997, 63:356–361.
Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67:352–360; discussion 360–362.
Furnary AP, Gao G, Grunkemeier GL, et al.: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003, 125:1007–1021.
O’Connor GT, Plume SK, Olmstead EM, et al.: A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. JAMA 1991, 266:803–809.
Lazar HL, Chipkin SR, Fitzgerald CA, et al.: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004, 109:1497–1502.
Leavitt BJ, O’Connor GT, Olmstead EM, et al.: Use of the internal mammary artery and in-hospital mortality and other adverse outcomes associated with coronary artery bypass surgery. Circulation 2001, 103:507–512.
Barsness GW, Peterson ED, Ohman EM, et al.: Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997, 96:2551–2556.
Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status [no authors listed]. J Am Coll Cardiol 2000, 35:1122–1129.
Thourani VH, Weintraub WS, Stein B, et al.: Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999, 67:1045–1052.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leavitt, B.J. The effects of diabetes mellitus on coronary artery bypass graft surgery. Curr Diab Rep 7, 20–24 (2007). https://doi.org/10.1007/s11892-007-0005-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11892-007-0005-7